BDBM506221 (S)-6-(( (Ml-(difluoromethyl)cyclopropyl)- 1H-1,2,3-triazol- 4-yl)(2-methyl-1-oxo-1,2- dihydroisoquinolin-5- yl)methyl)amino)-4- (neopentylamino)quinoline- 3,8-dicarbonitrile::US11066414, Compound 871

SMILES Cn1ccc2c(cccc2c1=O)[C@H](Nc1cc(C#N)c2ncc(C#N)c(NCC(C)(C)C)c2c1)C1=CN(NN1)C1(CC1)C(F)F

InChI Key InChIKey=RDIDZEOLUYHRTC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 506221   

TargetEpidermal growth factor receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM506221(US11066414, Compound 871 | (S)-6-(( (Ml-(difluorom...)
Affinity DataIC50: 1nMAssay Description:EGFR activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, EGFR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2021
Entry Details
US Patent